The trademark application RESDAARVY was filed by Atea Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 14, 2021, and it was registered by office on September 21, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on August 25, 2021. A transfer of the trademark registration was recorded on May 22, 2022. Change of name and professional address of the trademark registration was recorded on April 29, 2024.